Composite Outcomes in Clinical Prediction Modeling: Are We Trying to Predict Apples and Oranges?


Journal

Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646

Informations de publication

Date de publication:
07 2022
Historique:
received: 18 12 2021
revised: 19 01 2022
accepted: 26 01 2022
pubmed: 28 3 2022
medline: 22 6 2022
entrez: 27 3 2022
Statut: ppublish

Résumé

Composite outcomes are widely used in clinical research. Existing literature has considered the pros and cons of composite outcomes in clinical trials, but their extensive use in clinical prediction has received much less attention. Clinical prediction assists decision-making by directing patients with higher risks of adverse outcomes toward interventions that provide the greatest benefits to those at the greatest risk. In this article, we summarize our existing understanding of the advantages and disadvantages of composite outcomes, consider how these relate to clinical prediction, and highlight the problem of key predictors having markedly different associations with individual components of the composite outcome. We suggest that a "composite outcome fallacy" may occur when a clinical prediction model is based on strong associations between key predictors and one component of a composite outcome (such as mortality) and used to direct patients toward intervention when these predictors actually have an inverse association with a more relevant component of the composite outcome (such as the use of a lifesaving intervention). We propose that clinical prediction scores using composite outcomes should report their accuracy for key components of the composite outcome and examine for inconsistencies among predictor variables.

Identifiants

pubmed: 35339284
pii: S0196-0644(22)00102-0
doi: 10.1016/j.annemergmed.2022.01.046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-19

Informations de copyright

Copyright © 2022 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Kieran Dash (K)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom. Electronic address: kieranrdash@gmail.com.

Steve Goodacre (S)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Laura Sutton (L)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH